Reply: An inverse association between tumour size and overdiagnosis may explain the results by Bucchi et al

[1]  Lymph node status in screen-detected cancers , 2005, British Journal of Cancer.

[2]  M. Federico,et al.  Screen-detected vs clinical breast cancer: the advantage in the relative risk of lymph node metastases decreases with increasing tumour size , 2004, British Journal of Cancer.

[3]  V. Kataja,et al.  Risk for distant recurrence of breast cancer detected by mammography screening or other methods. , 2004, JAMA.

[4]  Jan Mæhlen,et al.  Incidence of breast cancer in Norway and Sweden during introduction of nationwide screening: prospective cohort study , 2004, BMJ : British Medical Journal.

[5]  J. Coebergh,et al.  Breast Cancers Found by Screening: Earlier Detection, Lower Malignant Potential or Both? , 2002, Breast Cancer Research and Treatment.

[6]  I. Vejborg,et al.  Breast cancer incidence after the start of mammography screening in Denmark , 2003, British Journal of Cancer.

[7]  Peter C Gøtzsche,et al.  Cochrane review on screening for breast cancer with mammography , 2001, The Lancet.

[8]  N. Wald,et al.  European Society of Mastology Consensus Conference on breast cancer screening: report of the evaluation committee. , 1994, The British journal of radiology.

[9]  A. Huggins,et al.  Comparative pathology of breast cancer in a randomised trial of screening. , 1991, British Journal of Cancer.

[10]  L. Tabár,et al.  Detection method, tumour size and node metastases in breast cancers diagnosed during a trial of breast cancer screening. , 1987, European journal of cancer & clinical oncology.